Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Reexamination Certificate
2007-02-13
2007-02-13
Kerr, Kathleen (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
C530S328000, C530S412000, C435S069700, C435S252300, C435S320100
Reexamination Certificate
active
10264480
ABSTRACT:
The invention provides isolated polypeptides from the venom of the scorpionP. transvaalicus. The invention also provides novel scorpion antivenom compositions derived from such polypeptides, as well as methods for isolating the polypeptides and preparing scorpion antivenom compositions. The isolated polypeptides can be used to produce pharmaceutical compositions useful for treating diseases and conditions associated with ion channel function or kinin activity.
REFERENCES:
patent: 2004/0031072 (2004-02-01), La Rosa et al.
patent: WO 00/24772 (2000-05-01), None
patent: WO 00/32777 (2000-06-01), None
patent: WO 00/78957 (2000-12-01), None
patent: WO 00/78958 (2000-12-01), None
Swerts et al. Development and optimization of a purification strategy go the venom of the scorpionParabuthus transvaalicus. 1997. Journal de pharmacie de Belgique 52 (5): 194-195.
Debont et al. Comparison and characterization of the venoms of threeParabuthusscorpion species occuring in Southern Africa. Feb. 1998. Toxicon 36 (2):341-352.
Inceoglu et al. “A single charged surface residue modifies the activity of ikitoxin, a beta-type Na+ channel toxin fromParabuthus transvaalicus,”Eur. J. Biochem., 2002, vol. 269, No. 2, pp. 5369-5376.
Inceoglu et al. “Isolation and characterization of a novel type of neurotoxic peptide from venom of the South African scorpionParabuthus transvaalicus(Buthidae),”Eur. J. Biochem., 2001, vol. 268, No. 20, pp. 5407-5413.
Chuang et al. “Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin,”Nature Neuroscience, 1998, vol. 1, No. 8, pp. 668-674.
Campbell et al., Clin. Exp. Pharm. Phys., 2001, (28): 1060-1065.
Couture et al, European J. Pharmacology, 2001, (429):161-176.
Fatani et al.. Toxicon. 1998. (3):523-36.
Ferreira et al., Toxicon, 1998, (36):31-39.
GenBank Accession Nos. P42717 Bethesda : National Library of Medicine 1995.
GenBank Accession Nos. 1601326C Bethesda : National Library of Medicine 1988.
GenBank Accession Nos. S39030 Bethesda : National Library of Medicine 1993.
GenBank Accession Nos. P12797 Bethesda : National Library of Medicine 1989.
GenBank Accession Nos. 0504194A Bethesda : National Library of Medicine 1979.
GenBank Accession Nos. A61339 Bethesda : National Library of Medicine 1976.
GenBank Accession Nos. CAD29346 Bethesda : National Library of Medicine 2005.
GenBank Accession Nos. CAC48026 Bethesda : National Library of Medicine 2001.
Ismail et al., Toxicon, 1992, (10):1257-79.
Kotovych et al Biochem, Cell Bio., 1998, (76): 257-266.
Meki et al., Peptides, 1995, 16(8):1359-65.
Hammock Bruce D.
Inceoglu Bora
Bozicevic, Field & Francis
Keddie James S.
Kerr Kathleen
Moore William W.
The Regents of the University of California
LandOfFree
Isolated polypeptides and compositions from the venom of P.... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated polypeptides and compositions from the venom of P...., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated polypeptides and compositions from the venom of P.... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3845229